DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Navigating the Rough Seas of Copay Accumulator Programs. Impacts, Trends and Mitigation Strategies for Pharma

This live session took place on February 7th, 2019

During 2018, PBMs began ramping up efforts to address drug spending through Copay Accumulator programs, which prevent manufacturer copay assistance amounts from being applied to a patient’s deductible or out-of-pocket maximum. In many therapy areas, patients rely on copay assistance programs (like drug coupons) that substantially reduce copayments and make therapy adherence easier. Copay Accumulators (and their close relative Copay Maximizers) are the latest move by insurers and pharmacy benefit managers to control drug expenditures at the expense of pharma and patients.
The impact of Copay Accumulator programs to pharma and patients will depend on a variety of factors, including drug costs, deductible levels, patient reliance on copay assistance programs, disease prevalence, drug substitutability, patient income, and the specific details and restrictions of copay assistance programs.
In this webinar, we will discuss trends related to copay accumulator and copay maximizer adoption, potential impacts of copay accumulator programs on high profile therapeutic areas and brands, and potential mitigation strategies for pharma.
Presenters:

  • Valerie Pillo (Host), Market Analyst with Market Access
  • Tyler Dinwiddie, Senior Market Analyst with Market Access

Introducing: Copay Accumulator Threat Assessor

Real world claims data, lives information and market research has come together to provide the most comprehensive copay accumulator database available in an easy to use dashboard. Get deep analysis on copay benefit design, understand business impact and gain informed, actionable insights.

Learn More